Pfizer's $50M EpiPen Deal Gets Final OK In Antitrust Suit
By Nadia Dreid · July 11, 2024, 8:43 PM EDT
Pfizer is officially out of a lawsuit accusing it of working with Mylan Pharmaceuticals to inflate the price of the popular auto-injecting emergency allergy medication EpiPen after a Kansas federal judge...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login